Oxytocin in Schizophrenia: Pathophysiology and Implications for Future Treatment
- PMID: 33670047
- PMCID: PMC7926349
- DOI: 10.3390/ijms22042146
Oxytocin in Schizophrenia: Pathophysiology and Implications for Future Treatment
Abstract
Schizophrenia is a form of mental disorder that is behaviorally characterized by abnormal behavior, such as social function deficits or other behaviors that are disconnected from reality. Dysregulation of oxytocin may play a role in regulating the expression of schizophrenia. Given oxytocin's role in social cognition and behavior, a variety of studies have examined the potential clinical benefits of oxytocin in improving the psychopathology of patients with schizophrenia. In this review, we highlight the evidence for the role of endogenous oxytocin in schizophrenia, from animal models to human studies. We further discuss the potential of oxytocin as a therapeutic agent for schizophrenia and its implication in future treatment.
Keywords: oxytocin; psychopathology; schizophrenia; social cognition.
Conflict of interest statement
The authors declare no conflict of interest.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
